Plain-English translation of NCT07635238 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach to radiation therapy for prostate cancer using advanced MRI-guided radiation technology. Researchers want to see if giving lower doses of radiation to the areas where cancer is visible on MRI scans—rather than the same dose to the whole prostate—can reduce uncomfortable side effects while still treating the cancer effectively.
Standard radiation therapy for prostate cancer treats the entire prostate with the same dose, which can cause side effects like urinary and bowel problems. This trial exists to find out whether focusing the radiation more precisely on visible tumors while using lower doses elsewhere might give patients the same cancer control with fewer side effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive radiation therapy using one of two approaches: either a uniform dose across the whole prostate, or a lower dose with a higher boost to the visible tumor areas. The treatment takes place over just 2 sessions using an advanced MRI-guided radiation machine. You will have follow-up visits to monitor your recovery, check for side effects, and ensure the treatment is working.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States